Calidi Biotherapeutics, Inc. (CLDI)
EBITDA Growth
30.50%
Quarterly · Period ending:
CLDI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported30.50%period ending
Latest reported30.50%period ending
CLDI Quarterly EBITDA YoY % (-45040.00% → 30.50%)
Year-over-year change
High-resolution chart · PNG
CLDI ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 30.5021% | |
| 20.749% | |
| 1.0184% | |
| -5.7329% | |
| -3.7197% | |
| 30.3458% | |
| 52.485% | |
| -230.9524% | |
| 56.8107% | |
| -8.8478% | |
| 13.084% | |
| 72.4928% | |
| -162.0071% | |
| -23.1301% | |
| -215.1917% | |
| -493.4733% | |
| -45,040% |